3 Weight-Loss Drug Stocks to Watch

Group 1: Hims & Hers Health Inc (HIMS) - HIMS shares increased by 17.5%, trading at $54.50, with a record peak of$56.71, marking a 438.7% year-over-year gain [2] - The company aired an advertisement during the Super Bowl and is preparing to release its fourth-quarter results on February 24 [2] - Historically, HIMS has experienced negative post-earnings reactions, with five out of the last eight sessions closing lower the day after earnings [2] Group 2: Novo Nordisk A/S (NVO) - NVO shares decreased by 3.1%, trading at $79.29, and have dropped 42.3$78.17, with five consecutive daily losses [3] - NVO has faced resistance at the $90 level since late December [3] Group 3: Viking Therapeutics Inc (VKTX) - VKTX shares fell by 2.1$28.70, and are on track for their fifth loss in the last six sessions [4] - The stock recently hit its lowest level in 12 months, despite receiving an "outperform" rating from Scotiabank with a price target of $102 [4] - VKTX has a 58.3% deficit over the past nine months and has declined by 28.5% this year [4]